Madrigal Pharmaceuticals
MDGL
MDGL
352 hedge funds and large institutions have $10.7B invested in Madrigal Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 87 funds opening new positions, 107 increasing their positions, 107 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
15% more funds holding
Funds holding: 305 → 352 (+47)
0% more repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 107
0.74% less ownership
Funds ownership: 106.08% → 105.34% (-0.74%)
Holders
352
Holding in Top 10
14
Calls
$326M
Puts
$258M
Top Buyers
| 1 | +$148M | |
| 2 | +$73.2M | |
| 3 | +$61.8M | |
| 4 |
BlackRock
New York
|
+$45.1M |
| 5 |
Alkeon Capital Management
New York
|
+$44.8M |
Top Sellers
| 1 | -$130M | |
| 2 | -$108M | |
| 3 | -$107M | |
| 4 |
PC
Paulson & Co
New York
|
-$67.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$59.3M |
